UPDATE 1-U.S. FDA approves Tandem's predictive insulin pump software
December 13, 2019 at 12:12 PM EST
The U.S. Food and Drug Administration on Friday granted approval for Tandem Diabetes Care's software program that uses readings from a continuous glucose monitor to predict and deliver corrective doses of insulin to patients using the company's t:slim X2 insulin pump.